Atypical hemolytic uremic syndrome is a rare condition involving abnormal activation of the complement system, which can damage small blood vessels and affect the kidneys and other organs. Understanding its risk factors can help explain why the condition develops in some people. Genetic changes affecting complement regulation.
Atypical hemolytic uremic syndrome, often called aHUS, is a rare disorder characterized by excessive or uncontrolled activation of the complement system, part of the body's immune defense. This process can damage the lining of small blood vessels and contribute to the formation of tiny blood clots. The kidneys are particularly vulnerable, and severe cases can result in significant kidney impairment. Risk factors can involve inherited genetic susceptibility as well as external triggers. Having a risk factor does not necessarily mean that a person will develop aHUS.
Genetic factors are among the most important contributors to susceptibility to aHUS. Variants in genes involved in controlling the complement system can interfere with the body's ability to regulate immune activity. These changes may increase the likelihood of abnormal complement activation.
Some people have a genetic predisposition without experiencing symptoms until another event triggers the condition. Genetic testing may sometimes help identify variants associated with complement regulation, although not every person with a suspected genetic change has an identifiable variant.
Common genetic considerations include:
Variants affecting complement-regulating proteins may increase susceptibility.
Changes involving genes such as CFH, CFI, CD46, C3, or CFB have been associated with aHUS.
A genetic predisposition does not always lead to disease.
Family history may be relevant in some cases.
Genetic testing can be considered as part of a specialist evaluation.
Although genetic susceptibility is important, aHUS episodes can occur following events that place additional stress on the body. These triggers may activate the complement system in individuals who are already predisposed to abnormal regulation.
Potential triggers and associated circumstances include:
Certain bacterial or viral infections
Pregnancy and the period following childbirth
Some medications
Organ transplantation
Autoimmune or inflammatory conditions
Major physical stress or serious illness
Certain medical procedures
It is important to distinguish aHUS from other forms of hemolytic uremic syndrome. For example, typical HUS is commonly associated with Shiga toxin producing bacterial infections, while aHUS is primarily related to complement system dysregulation. Doctors may use laboratory testing and clinical assessment to determine the likely cause.
Atypical hemolytic uremic syndrome can result from a combination of underlying susceptibility and external triggers. Genetic changes affecting complement regulation are important risk factors, but infections, pregnancy, medications, transplantation, and other stresses may contribute to disease episodes. Because aHUS can affect kidney function and other organs, unexplained anemia, low platelet levels, or signs of kidney problems require appropriate medical evaluation. Understanding the potential risk factors can provide useful background for patients and families while supporting informed discussions with qualified healthcare professionals.